Evidence map›Paper›PMID 36370261›Full record

ReviewStem cell reviews and reports2023

Duplication Versus Deletion Through the Lens of 15q13.3: Clinical and Research Implications of Studying Copy Number Variants Associated with Neuropsychiatric Disorders in Induced Pluripotent Stem Cell-Derived Neurons.

Irene Antony, Mishka Narasimhan, Renata Shen, Ramachandran Prakasam, Komal Kaushik, Gareth Chapman, Kristen L Kroll

Open access · greenAbstract readReview
In one paragraph

Review in Stem cell reviews and reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Irene AntonyDepartment of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Mishka NarasimhanDepartment of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Renata ShenDepartment of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Ramachandran PrakasamDepartment of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Komal KaushikDepartment of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Gareth ChapmanDepartment of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Kristen L KrollDepartment of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, 63110, USA. kkroll@wustl.edu.
Washington University in St. Louis · US

Funding

WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JEFFREY D MILBRANDT · 2020 to 2026
$15.5M
Genomic and functional characterization of ASD and ID-associated MYT1L mutationR01MH124808 · NIMH · WASHINGTON UNIVERSITY · PI KROLL, KRISTEN L · 2021 to 2025
$3.7M
The cis-regulatory grammar and epigenetic control of human interneuron progenitor specificationR01NS114551 · NINDS · WASHINGTON UNIVERSITY · PI KROLL, KRISTEN L · 2021 to 2024
$2.1M
The cis-regulatory grammar and epigenetic control of human interneuron progenitor specificationR56NS114551 · NINDS · WASHINGTON UNIVERSITY · PI KROLL, KRISTEN L · 2020 to 2020
$436k
NICHD NIH HHS P50 HD103525NIMH NIH HHS R01 MH124808NINDS NIH HHS R01 NS114551NINDS NIH HHS R56 NS114551
6 · The paper itself

Abstract

Copy number variants (CNVs), involving duplication or deletion of susceptible intervals of the human genome, underlie a range of neurodevelopmental and neuropsychiatric disorders. As accessible in vivo animal models of these disorders often cannot be generated, induced pluripotent stem cell (iPSC) models derived from patients carrying these CNVs can reveal alterations of brain development and neuronal function that contribute to these disorders. CNVs involving deletion versus duplication of a particular genomic interval often result both in distinct clinical phenotypes and in differential phenotypic penetrance. This review initially focuses on CNVs at 15q13.3, which contribute to autism spectrum disorder, attention deficit/hyperactivity disorder, and schizophrenia. Like most CNVs, deletions at 15q13.3 usually cause severe clinical phenotypes, while duplications instead result in highly variable penetrance, with some carriers exhibiting no clinical phenotype. Here, we describe cellular and molecular phenotypes seen in iPSC-derived neuronal models of 15q13.3 duplication and deletion, which may contribute both to the differential clinical consequences and phenotypic penetrance. We then relate this work to many other CNVs involving both duplication and deletion, summarizing findings from iPSC studies and their relationship to clinical phenotype. Together, this work highlights how CNVs involving duplication versus deletion can differentially alter neural development and function to contribute to neuropsychiatric disorders. iPSC-derived neuronal models of these disorders can be used both to understand the underlying neurodevelopmental alterations and to develop pharmacological or molecular approaches for phenotypic rescue that may suggest leads for patient intervention. Top: Deletion versus duplication of the same genomic interval results in different clinical phenotypes and degrees of phenotypic penetrance. Example findings schematized. Bottom: iPSC-derived neurons from individuals with these CNVs involving deletion versus duplication likewise often differential phenotypes (increases or decreases) in the categories shown. Figure created with BioRender.com.

Indexed as

Autism Spectrum DisorderInduced Pluripotent Stem CellsAnimalsDNA Copy Number VariationsHumansNeuronsPhenotype15q13.3Autism spectrum disorderCHRNA7Copy number variantDeletionDuplicationInduced pluripotent stem cellNeurodevelopmental disorderNeuronNeuropsychiatric disorder

Identifiers

PMID36370261
PMCPMC10115185
OpenAlexW4308834795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.